Intensive care, survival, and expense of treating critically ill cancer patients.
Objective.-To determine the survival and factors affecting the survival of patients with solid tumors and hematologic cancers who were admitted to the intensive care unit, the time these patients spent at home (meaningful survival) before they died, and the cost per year of life gained and per year of life gained at home.
Design.-Survival and cost-effectiveness analysis.
Setting.-A tertiary-care cancer center at a university medical center.
Patients.-Every patient admitted to the intensive care unit between July 1, 1988, and June 30, 1990, was entered into the study.
This group comprised 83 patients with solid tumors and 64 patients with hematologic cancers.
Mots-clés Pascal : Hémopathie maligne, Economie santé, Tumeur maligne, Homme, Etude statistique, Survie, Analyse coût efficacité, Unité soin intensif, Tumeur solide
Mots-clés Pascal anglais : Malignant hemopathy, Health economy, Malignant tumor, Human, Statistical study, Survival, Cost efficiency analysis, Intensive care unit, Solid tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0334122
Code Inist : 002B30A04B. Création : 199406.